Medicare Enrolled
Dr. Jennifer Cultrera, M.D.
Hematology · Lady Lake, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Cultrera from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cultrera? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Cultrera
Dr. Jennifer Cultrera is a hematology in Lady Lake, FL, with 19 years in practice. Based on federal Medicare data, Dr. Cultrera performed 232,478 Medicare services across 6,069 unique beneficiaries.
Between the years covered by Open Payments, Dr. Cultrera received a total of $100,920 from 82 pharmaceutical and/or device companies across 890 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Cultrera is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 16% volume in FL$ $100,920 industry payments
Medicare Practice Summary
Medicare Utilization ↗232,478
Medicare services
Top 16% in FL for hematology
6,069
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~12,236 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 70,890 | $0 | $4 |
| Filgrastim injection (Zarxio) for white blood cells | 35,580 | $0 | $2 |
| Iron infusion (Injectafer) | 19,500 | $1 | $3 |
| Iron sucrose injection (Venofer) | 15,500 | $0 | $5 |
| Pembrolizumab injection (Keytruda) | 14,800 | $43 | $137 |
| Denosumab injection (Prolia/Xgeva) | 14,700 | $18 | $51 |
| Anti-nausea injection (aprepitant) | 14,690 | $1 | $5 |
| Epoetin alfa injection (Procrit) for anemia | 7,710 | $6 | $23 |
| Immune globulin infusion (Gammagard) | 7,362 | $36 | $108 |
| Iron infusion (Monoferric) | 6,800 | $17 | $57 |
| Complete blood count (CBC) with differential | 3,244 | $8 | $29 |
| Blood draw (venipuncture) | 3,093 | $8 | $9 |
| Infliximab infusion (Remicade) | 2,855 | $26 | $124 |
| Dexamethasone injection (steroid) | 2,744 | $0 | $3 |
| Office visit, established patient (30-39 min) | 2,088 | $94 | $339 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,480 | $1 | $28 |
| Drug injection, under skin or into muscle | 1,402 | $10 | $69 |
| Anti-nausea injection (ondansetron/Zofran) | 836 | $0 | $9 |
| Injection, leucovorin calcium, per 50 mg | 817 | $3 | $12 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 727 | $1 | $6 |
| Injection of additional new drug or substance into vein | 689 | $12 | $61 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 560 | $47 | $189 |
| Administration of chemotherapy into vein, 1 hour or less | 499 | $97 | $378 |
| Injection, fluorouracil, 500 mg | 439 | $2 | $7 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 289 | $16 | $56 |
| Injection, magnesium sulfate, per 500 mg | 238 | $1 | $2 |
| Administration of chemotherapy into vein, each additional hour | 220 | $21 | $79 |
| Injection, diphenhydramine hcl, up to 50 mg | 220 | $1 | $3 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 205 | $22 | $84 |
| Infusion into a vein for hydration, each additional hour | 190 | $10 | $42 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 178 | $3 | $11 |
| Injection, zoledronic acid, 1 mg | 164 | $6 | $69 |
| Office visit, established patient (20-29 min) | 149 | $66 | $239 |
| Initial hospital admission, high complexity | 143 | $133 | $556 |
| New patient office visit (45-59 min) | 141 | $120 | $453 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 131 | $16 | $59 |
| Administration of additional new drug or substance into vein, 1 hour or less | 115 | $49 | $178 |
| Injection of drug or substance into vein | 114 | $27 | $156 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 101 | $55 | $206 |
| Infusion, normal saline solution , 1000 cc | 98 | $2 | $7 |
| Hospital follow-up visit, high complexity | 91 | $93 | $285 |
| Infusion into a vein for hydration, 31-60 minutes | 90 | $24 | $156 |
| Administration of additional new drug or substance into vein using push technique | 81 | $42 | $170 |
| Red blood count automated, with additional calculations | 79 | $5 | $20 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 68 | $25 | $89 |
| Automated urinalysis | 65 | $2 | $8 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 61 | $1 | $7 |
| Telephone medical discussion with physician, 5-10 minutes | 40 | $29 | $115 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 34 | $126 | $637 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 29 | $15 | $56 |
| Office visit, established patient, complex (40-54 min) | 27 | $140 | $474 |
| Drawing of blood for a medical problem | 23 | $57 | $277 |
| Telephone medical discussion with physician, 11-20 minutes | 22 | $64 | $192 |
| Telephone medical discussion with physician, 21-30 minutes | 20 | $90 | $282 |
| Prothrombin time test (blood clotting) | 19 | $4 | $15 |
| Red blood count, automated test | 16 | $4 | $10 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | 12 | $176 | $587 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
46.9% high complexity
49.0% medium
4.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$100,920
Total received (2018-2024)
Avg $14,417/year across 7 years
Top 4% in FL for hematology
82
Companies
890
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$83,574 (82.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,374 (13.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,973 (3.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,537
2023$2,128
2022$1,719
2021$1,512
2020$7,712
2019$29,229
2018$57,083
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$41,727
Celgene Corporation
$25,823
Spectrum Pharmaceuticals Inc.
$10,004
Aurobindo Pharma USA, Inc.
$6,546
Verastem, Inc.
$4,014
Janssen Biotech, Inc.
$1,314
Novartis Pharmaceuticals Corporation
$1,085
E.R. Squibb & Sons, L.L.C.
$758
Genentech USA, Inc.
$585
AstraZeneca Pharmaceuticals LP
$506
Octapharma USA, Inc.
$501
Merck Sharp & Dohme Corporation
$472
Incyte Corporation
$427
PFIZER INC.
$398
Foundation Medicine, Inc.
$368
GENZYME CORPORATION
$348
Daiichi Sankyo Inc.
$314
Lilly USA, LLC
$307
Gilead Sciences, Inc.
$304
Bayer HealthCare Pharmaceuticals Inc.
$287
F. Hoffmann-La Roche AG
$258
BeiGene USA, Inc.
$248
Astellas Pharma US Inc
$248
Pharmacyclics LLC, An AbbVie Company
$228
Eisai Inc.
$218
Alexion Pharmaceuticals, Inc.
$210
ABBVIE INC.
$195
Clovis Oncology, Inc.
$191
EISAI INC.
$143
Agios Pharmaceuticals, Inc.
$133
EMD Serono, Inc.
$130
Takeda Pharmaceuticals U.S.A., Inc.
$130
JAZZ PHARMACEUTICALS INC.
$128
ARRAY BIOPHARMA INC
$127
GlaxoSmithKline, LLC.
$127
Kite Pharma, Inc.
$115
G1 Therapeutics, Inc.
$110
Boehringer Ingelheim Pharmaceuticals, Inc.
$106
AMAG Pharmaceuticals, Inc.
$105
CTI BioPharma Corp.
$102
Taiho Oncology, Inc.
$92
Exelixis Inc.
$82
Seagen Inc.
$78
MorphoSys, US Inc.
$74
Merck Sharp & Dohme LLC
$71
Bayer Healthcare Pharmaceuticals Inc.
$69
Kyowa Kirin, Inc.
$68
Array BioPharma Inc.
$63
TESARO, Inc.
$62
Mirati Therapeutics, Inc.
$59
Heron Therapeutics, Inc.
$56
Ipsen Biopharmaceuticals, Inc
$54
Stemline Therapeutics Inc.
$51
Seattle Genetics, Inc.
$50
Karyopharm Therapeutics Inc.
$50
AbbVie Inc.
$44
Rigel Pharmaceuticals, Inc.
$41
Global Blood Therapeutics, Inc.
$40
Dendreon Pharmaceuticals LLC
$40
Boston Scientific Corporation
$39
Pharmacyclics LLC, an AbbVie Company
$36
Teva Pharmaceuticals USA, Inc.
$35
Lexicon Pharmaceuticals, Inc.
$33
Puma Biotechnology, Inc.
$26
Regeneron Healthcare Solutions, Inc.
$25
Telix Pharmaceuticals
$23
TerSera Therapeutics LLC
$21
PUMA BIOTECHNOLOGY, INC.
$18
Alnylam Pharmaceuticals Inc.
$17
AVEO Pharmaceuticals, Inc.
$16
Jazz Pharmaceuticals Inc.
$16
Emmaus Medical, Inc.
$15
Dova Pharmaceuticals
$15
MEDIVATION FIELD SOLUTIONS LLC
$14
PharmaEssentia USA Corporation
$14
Deciphera Pharmaceuticals Inc.
$13
Secura Bio, Inc.
$13
AbbVie, Inc.
$13
NanoString Technologies, Inc.
$12
GE HEALTHCARE
$12
SECURA BIO, INC.
$12
Veracyte, Inc.
$2
Top 3 companies account for 76.8% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · Alecensa · Aliqopa · Avastin · BAVENCIO · BENDEKA · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Blincyto · Braftovi · CABLIVI · CALQUENCE · CEREZYME · CINVANTI · COPIKTRA · COSELA · CYRAMZA · Cabometyx · Cinvanti · Copiktra · DARZALEX · Doptelet · ELAHERE · ELIQUIS · ELITEK · ELREXFIO · ENHERTU · EPKINLY · ERBITUX · ERLEADA · EVENITY · Endari · Enhertu · Erivedge · Erleada · FARYDAK · FERAHEME · FOTIVDA · FOUNDATIONONE · FOUNDATIONONE CDX · Fabhalta · Folotyn · GAZYVA · GILOTRIF · GIVLAARI · Halaven · IBRANCE · ILLUCCIX · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · Inrebic · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · OPDIVO · OPDUALAG · OXBRYTA · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROSIGNA ASSAY · PROVENGE · PYRUKYND · Padcev · Perjeta · Phesgo · Pomalyst · Prolia · QINLOCK · REBLOZYL · RYBREVANT · Revlimid · Rituxan Hycela · Rubraca · SANCUSO · SARCLISA · SCEMBLIX · SHINGRIX · SOLIRIS · SOMATULINE DEPOT · SUSTOL · SUTENT · Somatuline Depot · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TECENTRIQ · TEVIMBRA · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VOTRIENT · VYXEOS · Venclexta · Vitrakvi · Vonjo · WaveWriter Alpha Prime 16 · XALKORI · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xtandi · ZEJULA · ZEPZELCA · ZYTIGA · Zevalin · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (83%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for hematology in FL.
Equivalent to $43 per 100 Medicare services performed
Geographic Context
Hematologys within 10 mi
9
Per 100K population
2.3
County median income
$69,956
Nearest hospital
VILLAGES REGIONAL HOSPITAL, THE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Cultrera is a mixed practice specialist, with above-average Medicare volume (top 16% in FL), and high industry engagement (speaking/promotional, top 4%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Cultrera experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Cultrera performed 70,890 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cultrera receive payments from pharmaceutical companies?
Yes. Dr. Cultrera received a total of $100,920 from 82 companies across 890 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cultrera's costs compare to other hematologys in Lady Lake?
Dr. Cultrera's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cultrera) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologys in Lady Lake
Browse hematologys in Lady Lake ranked by procedure volume and transparency data.
Highest volume
Top Hematologys in FL
Hematologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologys in FL
Which FL hematologys receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc..
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
Spectrum Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Spectrum Pharmaceuticals Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology